Core contributor across WEARPLEX (stretchable electrodes), iRel40 (chip-package-board reliability), and MedPhab (photonics device manufacturing).
SCREENTEC OY
Finnish SME specializing in screen-printed flexible electronics for biomedical wearables, medical diagnostics, and pilot-scale device manufacturing.
Their core work
Screentec is a Finnish SME specializing in screen-printed and flexible electronics manufacturing, based in Oulu. They produce stretchable biomedical electrodes, printed sensors, and functional material components used in wearable health monitoring and medical diagnostics. Their manufacturing expertise extends to rapid production line adaptation, as demonstrated during the COVID-19 crisis when they contributed to repurposing manufacturing capacity for medical PPE and ventilator components. They sit at the intersection of printed electronics fabrication and medtech applications, providing pilot-scale manufacturing capabilities to research consortia.
What they specialise in
WEARPLEX focused on stretchable multi-pad biomedical electrodes; MedPhab on photonics-based medical diagnostics at pilot scale.
iRel40 project addressed Quality 4.0, physics of failure, robustness validation, and design for reliability in electronic systems.
RESERVIST project involved repurposing manufacturing lines for PPE, respiratory ventilators, and medical face masks during health emergencies.
How they've shifted over time
Screentec's H2020 participation spans a compact window (2019–2020 start dates), but a clear shift is visible. Their earliest projects focused on biomedical wearables and medical diagnostics — direct applications of their printed electronics expertise. Their later projects broadened into electronics reliability (Quality 4.0, physics of failure) and emergency manufacturing repurposing, suggesting growing interest in making their production capabilities more robust, validated, and adaptable to crisis scenarios.
Screentec is evolving from a pure printed electronics fabricator toward a reliability-validated, flexible manufacturer capable of pivoting production lines for medical emergencies — a profile increasingly valued post-COVID.
How they like to work
Screentec exclusively participates as a consortium partner, never as coordinator, which is typical for a specialized manufacturing SME contributing specific fabrication capabilities to larger research initiatives. With 125 unique partners across 20 countries from just 4 projects, they operate in large consortia (averaging 30+ partners per project). This suggests they are sought after as a reliable manufacturing partner rather than a project initiator — a company you bring in when you need someone who can actually produce the hardware.
Despite only 4 projects, Screentec has built connections with 125 unique partners across 20 countries, reflecting participation in major pan-European consortia. Their network is heavily European with no apparent geographic concentration beyond their Finnish base.
What sets them apart
Screentec occupies a rare niche: an SME that can take printed and flexible electronics from lab concept to pilot-scale manufacturing, specifically for biomedical applications. Their Oulu location places them in Finland's strong electronics ecosystem (Nokia legacy region), giving them access to deep printed electronics talent. The combination of wearable electrode fabrication, reliability engineering knowledge, and demonstrated ability to repurpose production lines for medical emergencies makes them a distinctive manufacturing partner for any consortium that needs to bridge the gap between research prototypes and physical products.
Highlights from their portfolio
- WEARPLEXLargest funding (EUR 305k) and most aligned with their core identity — developing stretchable multi-pad biomedical electrodes for wearable health applications.
- RESERVISTDemonstrates manufacturing agility during the COVID-19 crisis, repurposing production lines for PPE, ventilators, and medical face masks — proving real-world adaptability.
- MedPhabLongest-running project (2020–2024) focused on pilot-scale photonics manufacturing for medical devices, signaling a sustained commitment to medtech production capabilities.